INTEGRA LIFESCIENCES HOLDING

Integra LifeSciences shares fell 3.4% to $12.12, down 25% since month‑end. With a $926M market cap and 52‑week high of $20.49, investors can assess its recent trend and valuation. Explore the latest price action and key metrics.

Integra Lifesciences (IART) rebounds 4.1%, nearing its 200‑day SMA amid investor optimism for orthopaedic and neuro‑surgical growth. Discover the upside.

Integra LifeSciences stock dives 11% as a Cincinnati flood exposes supply‑chain risk; despite positive earnings, market doubts keep prices below the 52‑week low.

Integra Lifesciences slides 0.89% as investors flag product concentration, cash‑flow limits, and reimbursement risk—why the stock lags peers and what could reverse the trend.

Integra LifeSciences stock up 1.82% to $13.33 on March 21, 2026 – see market cap, 52‑week swing, and peer comparison for key investor insights.